ArticlePLOS digital health2025
Image Imputation with conditional generative adversarial networks captures clinically relevant imaging features on computed tomography.
Article in PLOS digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kidney cancer is among the top 10 most common malignancies in adults, and is commonly evaluated with four-phase computed tomography (CT) imaging. However, the presence of missing or corrupted images remains a significant problem in medical imaging that impairs the detection, diagnosis, and treatment planning of kidney cancer. Deep learning approaches through conditional generative adversarial networks (cGANs) have recently shown technical promise in the task of imputing missing imaging data from these four-phase studies. In this study, we explored the clinical utility of these imputed images. We utilized a cGAN trained on 333 patients, with the task of the cGAN being to impute the image of any phase given the other three phases. We tested the clinical utility on the imputed images of the 37 patients in the test set by manually extracting 21 clinically relevant imaging features and comparing them to their ground truth counterpart. All 13 categorical clinical features had greater than 85% agreement rate between true images and their imputed counterparts. This high accuracy is maintained when stratifying across imaging phases. Imputed images also show good agreement with true images in select radiomic features including mean intensity and enhancement. Imputed images possess the features characteristic of benign or malignant diagnosis at an equivalent rate to true images. In conclusion, imputed images from cGANs have large potential for clinical use due to their ability to retain clinically relevant qualitative and quantitative features.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.